Novo Nordisk GLP-1 competition Warning with new pill rival
Can Novo Nordisk defend its GLP-1 dominance as a potent oral rival emerges and a bold US telehealth deal reshapes distribution? How does Structure Therapeutics…
Tesla Robotaxi Strategy Boom as EV Sales Plunge
Can Tesla’s bold Robotaxi Strategy and energy storage pivot really justify a trillion-dollar valuation as its core EV business slows? How is Tesla reshaping its…